EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 377 filers reported holding EXELIXIS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $86,750,000 | +11.6% | 3,548,070 | +8.4% | 0.64% | -4.0% |
| Q2 2020 | $77,728,000 | +86.8% | 3,274,157 | +35.5% | 0.67% | +50.1% |
| Q1 2020 | $41,613,000 | +574.8% | 2,416,532 | +590.4% | 0.45% | +727.8% |
| Q4 2019 | $6,167,000 | -83.5% | 350,000 | -79.2% | 0.05% | -85.7% |
| Q1 2018 | $37,352,000 | +145.7% | 1,686,400 | +237.3% | 0.38% | +140.1% |
| Q4 2017 | $15,200,000 | +527.3% | 500,000 | +400.0% | 0.16% | +481.5% |
| Q3 2017 | $2,423,000 | -48.2% | 100,000 | -47.4% | 0.03% | -57.1% |
| Q2 2017 | $4,680,000 | +44.0% | 190,000 | +26.7% | 0.06% | +28.6% |
| Q1 2017 | $3,251,000 | +32.2% | 150,000 | -9.1% | 0.05% | +25.6% |
| Q4 2016 | $2,460,000 | – | 165,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |